通过调节MCM7表达,CircMCM7促进肝细胞癌细胞增殖和转移
Cheng Wang1, Lili Yan2, Meimei Xu2
1Department of Hepatobiliary Surgery, People's Hospital of Gong'an County, Jingzhou, Hubei, China.
Journal of biochemical and molecular toxicology
|January 8, 2026
概括
循环RNA circMCM7在肝细胞癌 (HCC) 中高度表达,促进癌症的进展. 抑制circMCM7抑制HCC细胞的增殖和入侵,为这种致命的癌症提供了潜在的新疗法.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 肝细胞癌 (HCC) 仍然是全球癌症死亡的主要原因.
- 目前对HCC的诊断和治疗策略存在局限性,需要新的生物标志物.
- 循环RNAs (circRNAs) 正在成为各种癌症的关键调节者,包括HCC.
研究的目的:
- 为了识别和描述参与HCC病变的新型circRNAs.
- 研究circMCM7在HCC细胞增殖,入侵和亡中的作用.
- 探索circMCM7作为HCC.治疗点的潜力.
主要方法:
- 对基因表达综合 (GEO) 数据库进行选,以确定circMCM7.
- 定量实时聚合酶连锁反应 (qRT-PCR) 用于circMCM7表达分析.
- 在体外测试 (CCK-8,EdU,Annexin V,Transwell) 和体内实验以评估circMCM7的功能.
- 西方涂抹和免疫组织化学 (IHC) 用于蛋白质表达分析.
主要成果:
- circMCM7在HCC组织中显著上调,与患者预后不佳相关.
- 由于其闭环结构,circMCM7表现出增强的稳定性.
- Knockdown 的 circMCM7 抑制了 HCC 细胞的增殖和入侵,并诱导了亡.
- circMCM7积极调节小染色体维护复合元件7 (MCM7) 的表达,影响HCC的进展.
结论:
- circMCM7通过促进细胞增殖,入侵和抑制细胞亡,充当HCC中的瘤性circRNA.
- circMCM7通过调节MCM7表达来调节HCC的进展.
- circMCM7代表了一种有前途的诊断生物标志物和肝细胞癌的治疗标.
关键词:
电路MCMCM7 电路MCM7 电路MCM7 MCM7 MCM7 MCM7 MCM7 MCM7 MCM7 MCM7 MCM7 MCM7 MCM7肝细胞癌是肝细胞癌.转移 转移 转移 转移它们的扩散和扩散.更多相关视频
10:18Exploring the Potential of Mesenchymal Stem Cell Sheet on The Development of Hepatocellular Carcinoma In Vivo
Published on: September 11, 2018
6.2K
08:50In Vitro Cultivation Techniques for Modeling Liver Organogenesis, Building Assembloids, and Designing Synthetic Tissues using Human Cell Lines
Published on: April 18, 2025
863
相关概念视频
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
Abnormal Proliferation
5.1K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
Induced Pluripotent Stem Cells
5.4K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
5.4K
MicroRNAs
3.8K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.8K
MicroRNAs
23.9K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.9K
